Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Surgical Option Examined for Treating Diabetic Neuropathies

By HospiMedica staff writers
Posted on 23 Jul 2008
Plastic surgeons and specialists in diabetes, neurology, pain management, and rehabilitation are launching a study of peripheral nerve surgery to alleviate long-standing pain and numbness in patients with symptomatic diabetic neuropathy with chronic nerve compression (DNND).

Researchers at the University of Texas (UT) Southwestern Medical Center (Dallas, TX, USA) are hoping to show that by releasing pressure from specific nerves of the DNND patients, pain may be decreased and sensation improved. More...
The study involves one year of close care and follow-up of 99 patients. As a part of the study, regular evaluations will be made by a foot care specialist, glucose management tips will be taught, and a specialized, non-invasive testing procedure will be conducted.

The risk of developing diabetic neuropathy increases the longer a person has diabetes, and it is estimated that up to 40% of diabetics have some form of neuropathy. About one-third of patients with diabetic neuropathy have overlying compression of certain nerves in the leg that may worsen the pain and cause loss of sensation at the bottom of the foot. Several studies have demonstrated that the nerves may increase in diameter in diabetic patients. For example, carpal tunnel syndrome, a medical term used to describe compression of the median nerve at the wrist, appears in approximately 2% percent of the general population, but in 15-30% of patients with diabetes. The treatment of choice in these patients, if conservative treatment has failed, is surgical nerve release.

In addition to pain, patients suffering from diabetic neuropathy have decreased sensation on the bottoms of their feet. Because they can injure their feet without noticing it, many develop ulcerations. Eventually, about one out of every six patients with ulcers will require an amputation, accounting for the nearly 100,000 amputations per year in the United States alone due to diabetes. Restoring protective sensation, so that diabetics will at least feel if they hit something with their foot, may decrease the amount of ulcers and eventual amputations in this high-risk population.

"Patients with neuropathy are often told that the problem is irreversible and that they cannot be helped,” said principal investigator Shai Rozen, M.D., an assistant professor of plastic surgery. "Diabetic neuropathy is a complex problem caused by multiple factors. We think pressure on nerves may be one component responsible for the symptoms in certain patients. This is very important to emphasize: Surgery may be helpful only in patients we suspect have pressure on their nerves in addition to their neuropathy and is not for all neuropathy patients.”


Related Links:
University of Texas Southwestern Medical Center

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.